Pituitary Dysfunction in Idiopathic Intracranial Hypertension: An Analysis of 80 Patients

Can J Neurol Sci. 2024 Mar;51(2):265-271. doi: 10.1017/cjn.2023.42. Epub 2023 Apr 4.

Abstract

Background: Empty sella is a commonly described imaging entity in patients with idiopathic intracranial hypertension (IIH). Though menstrual and hormonal disturbances have been associated with IIH, available literature lacks systematic analysis of pituitary hormonal disturbances in IIH. More so, the contribution of empty sella in causing pituitary hormonal abnormalities in patients of IIH has not been described. We carried out this study to systematically assess the pituitary hormonal abnormalities in patients with IIH and its relation to empty sella.

Methods: Eighty treatment naïve patients of IIH were recruited as per a predefined criterion. Magnetic resonance imaging (MRI) brain with detailed sella imaging and pituitary hormonal profile were done in all patients.

Results: Partial empty sella was seen in 55 patients (68.8%). Hormonal abnormalities were detected in 30 patients (37.5%), reduced cortisol levels in 20%, raised prolactin levels in 13.8%, low thyroid-stimulating hormone (TSH) levels in 3.8%, hypogonadism in 1.25%, and elevated levels of gonadotropins were found in 6.25% of participants. Hormonal disturbances were independent and were not associated with the presence of empty sella (p = 0.493).

Conclusion: Hormonal abnormalities were observed in 37.5% patients with IIH. These abnormalities did not correlate with the presence or absence of empty sella. Pituitary dysfunction appears to be subclinical in IIH and responds to intracranial pressure reduction, not requiring specific hormonal therapies.

Keywords: Empty sella; Idiopathic intracranial hypertension; Pituitary dysfunction.

MeSH terms

  • Empty Sella Syndrome* / complications
  • Empty Sella Syndrome* / diagnostic imaging
  • Humans
  • Intracranial Hypertension* / etiology
  • Magnetic Resonance Imaging / methods
  • Neuroimaging
  • Pseudotumor Cerebri* / complications
  • Pseudotumor Cerebri* / diagnostic imaging